Louiza Kalokairinou
Biographic Data
| ID | 4781725 |
|---|---|
| NAME | Louiza Kalokairinou |
| GIVEN NAMES | Louiza |
| FAMILY NAME | Kalokairinou |
| SIGNATURE | KALOKAIRINOU L |
| AFFILIATIONS | KU Leuven |
| ORCID | 0000-0002-5787-6535 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2017 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Neurofeedback as placebo
The use of placebo in clinical practice has been the topic of extensive debate in the bioethics literature, with much scholarship focusing on concerns regarding deception. While considerations of placebo without deception have largely centred on open-label placebo, this paper considers a different kind of ethical quandary regarding placebo without an intent to deceive—one where the provider believes a treatment is effective due to a direct physio…
Attitudes and experiences of European clinical geneticists towards direct-to-consumer genetic testing
Direct-to-consumer (DTC) genetic tests (GT) enable consumers to access a wide range of GT, without involving a healthcare professional, promoting an increasing disassociation of genetics from the clinical context. This study explores, through semi-structured interviews, the experiences and attitudes of European clinical geneticists towards DTCGT. Our results indicate that the participants have limited experience of consultations with patients reg…
Legislation of direct-to-consumer genetic testing in Europe
Despite the increasing availability of direct-to-consumer (DTC) genetic testing, it is currently unclear how such services are regulated in Europe, due to the lack of EU or national legislation specifically addressing this issue. In this article, we provide an overview of laws that could potentially impact the regulation of DTC genetic testing in 26 European countries, namely Austria, Belgium, Cyprus, the Czech Republic, Denmark, Estonia, Finland…
No prominent works on this page.
Legislation of direct-to-consumer genetic testing in Europe
Despite the increasing availability of direct-to-consumer (DTC) genetic testing, it is currently unclear how such services are regulated in Europe, due to the lack of EU or national legislation specifically addressing this issue. In this article, we provide an overview of laws that could potentially impact the regulation of DTC genetic testing in 26 European countries, namely Austria, Belgium, Cyprus, the Czech Republic, Denmark, Estonia, Finland…
Attitudes and experiences of European clinical geneticists towards direct-to-consumer genetic testing
Direct-to-consumer (DTC) genetic tests (GT) enable consumers to access a wide range of GT, without involving a healthcare professional, promoting an increasing disassociation of genetics from the clinical context. This study explores, through semi-structured interviews, the experiences and attitudes of European clinical geneticists towards DTCGT. Our results indicate that the participants have limited experience of consultations with patients reg…
Neurofeedback as placebo
The use of placebo in clinical practice has been the topic of extensive debate in the bioethics literature, with much scholarship focusing on concerns regarding deception. While considerations of placebo without deception have largely centred on open-label placebo, this paper considers a different kind of ethical quandary regarding placebo without an intent to deceive—one where the provider believes a treatment is effective due to a direct physio…
Medicine (3 works) · Political science (3 works) · Biomedical Ethics and Regulation (2 works) · BRCA gene mutations in cancer (2 works) · Genetic testing (2 works) · Law (2 works) · Psychology (2 works) · Social Psychology (2 works) · Alternative medicine (1 work) · Biotechnology and Related Fields (1 work)